Cargando…

PS153. Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial

Detalles Bibliográficos
Autores principales:	Heo, Jung Yoon, Jeon, Hong Jin, Fava, Maurizio, Mischoulon, David, Baer, Lee, Clain, Alisabet, Doorley, James, Pisoni, Angela, Papakostas, George I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616749/ http://dx.doi.org/10.1093/ijnp/pyw043.153

Ejemplares similares

Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder
por: Baek, Ji Hyun, et al.
Publicado: (2016)

Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression
por: Laferton, Johannes A. C., et al.
Publicado: (2018)

Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine
por: Yang, Huaiyu, et al.
Publicado: (2010)

Successful Ziprasidone Monotherapy in a Case of Delusional Parasitosis: A One-Year Followup
por: De Berardis, Domenico, et al.
Publicado: (2013)

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
por: Shi, Hui, et al.
Publicado: (2022)

PS89. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study
por: Kim, Kiwon, et al.
Publicado: (2016)

Ziprasidone in the Treatment of Delusional Parasitosis
por: Contreras-Ferrer, P., et al.
Publicado: (2012)

Ziprasidone in the treatment of mania in bipolar disorder
por: Nicolson, Stephen E, et al.
Publicado: (2007)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

A Case Report of Priapism Caused by Ziprasidon
por: Karamustafalioglu, Nesrin, et al.
Publicado: (2013)

Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
por: Mattei, Chiara, et al.
Publicado: (2011)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State
por: Patkar, Ashwin, et al.
Publicado: (2012)

The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study
por: Wu, Yaxue, et al.
Publicado: (2023)

Evidence review and clinical guidance for the use of ziprasidone in Canada
por: Gardner, David M, et al.
Publicado: (2013)

Case Report: Ziprasidone induced neuroleptic malignant syndrome
por: Sedhai, Yub Raj, et al.
Publicado: (2021)

PS90. Differences in hypochondriasis between Korean and American outpatients with major depressive disorder
por: Kim, Jiyeon, et al.
Publicado: (2016)

Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study
por: Papakostas, George I., et al.
Publicado: (2020)

Nonisothermal Kinetics Analysis of the Dehydration of Ziprasidone Hydrochloride Monohydrate by Thermogravimetry
por: Ravikiran, A., et al.
Publicado: (2013)

Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone
por: Khan, Afshan A, et al.
Publicado: (2010)

Ziprasidone as Adjunctive Therapy in Severe Bipolar Patients Treated with Clozapine
por: Bartolommei, Natalia, et al.
Publicado: (2014)

Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder
por: Ramaswamy, Sriram, et al.
Publicado: (2015)

Efficacy of Ziprasidone in Controlling Agitation during Post-Traumatic Amnesia
por: Noé, Enrique, et al.
Publicado: (2007)

Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?
por: Platanić Arizanović, Lena, et al.
Publicado: (2023)

PS281. Lifetime suicidal ideation and attempt in community adults with full major depressive disorder versus only sustained depressed mood
por: Yoo, Hye Jin, et al.
Publicado: (2016)

Effect of Korean Red Ginseng in individuals exposed to high stress levels: a 6-week, double-blind, randomized, placebo-controlled trial
por: Baek, Ji Hyun, et al.
Publicado: (2019)

Ziprasidone and its Association with Sudden Cardiac Death - A Case Report
por: Sidana, Ajeet, et al.
Publicado: (2004)

Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans
por: Gubert, Priscila, et al.
Publicado: (2013)

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson’s Disease
por: Younce, John R., et al.
Publicado: (2019)

Ziprasidone-Induced Oculogyric Crisis in a 74-Year-Old Female
por: Wilson, Alphonso, et al.
Publicado: (2020)

Restless legs syndrome following the use of ziprasidone: a case report
por: Zhu, Cuizhen, et al.
Publicado: (2020)

Are there anxious genes?
por: Morris-Rosendahl, Deborah J.
Publicado: (2002)

An Anxious Succession
Publicado: (1893)

An Anxious Doctor
Publicado: (1891)

PS99. First episode depression and monotherapy with escitalopram: A 16-week, open-label, flexible-dose study
por: Ravindran, Arun V., et al.
Publicado: (2016)

Ziprasidone-induced skin reaction : A case report from Indian subcontinent.
por: Jhirwal, O.P., et al.
Publicado: (2003)

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder
por: Bowden, Charles L
Publicado: (2011)

Clinical Outcomes in Patients Taking Inhaled Loxapine, Haloperidol, or Ziprasidone in the Emergency Department
por: McDowell, Marc, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qo1e2940078hkod8b8ru0nvndt